Brain volume change after high-dose immunosuppression and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis

Brain Volume ◽

Hematopoietic Cell ◽

High Dose ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)

JAMA Neurology ◽

10.1001/jamaneurol.2014.3780 ◽

2015 ◽

Vol 72 (2) ◽

pp. 159 ◽

Cited By ~ 105

Author(s):

Richard A. Nash ◽

George J. Hutton ◽

Michael K. Racke ◽

Uday Popat ◽

Steven M. Devine ◽

...

Keyword(s):

Multiple Sclerosis ◽

Immunosuppressive Therapy ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

High Dose ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis ◽

Treatment of Severe Relapsing-Remitting Multiple Sclerosis with High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation: 2-Year Follow-up Results of the HALT MS Clinical Trial (Immune Tolerance Network: ITN033AI)

10.1016/j.bbmt.2012.11.062 ◽

2013 ◽

Vol 19 (2) ◽

pp. S129 ◽

Cited By ~ 2

Author(s):

Richard Nash ◽

George J. Hutton ◽

Michael Racke ◽

Uday Popat ◽

Steven M. Devine ◽

...

Keyword(s):

Multiple Sclerosis ◽

Clinical Trial ◽

Immunosuppressive Therapy ◽

Immune Tolerance ◽

High Dose ◽

Relapsing Remitting ◽

Relapsing Remitting Multiple Sclerosis ◽

Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results

Bone Marrow Transplantation ◽

10.1038/bmt.2011.208 ◽

2011 ◽

Vol 47 (7) ◽

pp. 946-951 ◽

Cited By ~ 46

Author(s):

J D Bowen ◽

G H Kraft ◽

A Wundes ◽

Q Guan ◽

K R Maravilla ◽

...

Keyword(s):

Multiple Sclerosis ◽

Immunosuppressive Therapy ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

Long Term Results ◽

High Dose ◽

High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphoma (PTCL): Analysis of Prognostic Factors

10.1016/j.bbmt.2011.02.008 ◽

2011 ◽

Vol 17 (10) ◽

pp. 1481-1489 ◽

Cited By ~ 25

Author(s):

Auayporn Nademanee ◽

Joycelynne M. Palmer ◽

Leslie Popplewell ◽

Ni-Chun Tsai ◽

Maria Delioukina ◽

...

Keyword(s):

Prognostic Factors ◽

T Cell ◽

Cell Transplantation ◽

Cell Lymphoma ◽

Hematopoietic Cell ◽

High Dose ◽

High Dose Therapy ◽

Peripheral T Cell Lymphoma ◽

Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma

10.1016/j.bbmt.2018.01.036 ◽

2018 ◽

Vol 24 (7) ◽

pp. 1379-1385 ◽

Cited By ~ 4

Author(s):

Luciano J. Costa ◽

Heather J. Landau ◽

Saurabh Chhabra ◽

Parameswaran Hari ◽

Racquel Innis-Shelton ◽

...

Keyword(s):

Multiple Myeloma ◽

Cell Transplantation ◽

Phase 1 ◽

Hematopoietic Cell ◽

High Dose ◽

Refractory Multiple Myeloma ◽

Preparative Regimen ◽

High Dose Melphalan ◽

Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

Leukemia ◽

10.1038/sj.leu.2402867 ◽

2003 ◽

Vol 17 (4) ◽

pp. 811-813 ◽

Cited By ~ 17

Author(s):

C Chabannon ◽

A-G Le Corroller ◽

F Viret ◽

C Eillen ◽

C Faucher ◽

...

Keyword(s):

Cost Effectiveness ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Hematopoietic Cell ◽

High Dose ◽

Poor Mobilizers ◽

Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review

10.1016/j.bbmt.2016.02.007 ◽

2016 ◽

Vol 22 (7) ◽

pp. 1182-1196 ◽

Cited By ~ 5

Author(s):

Josephine A. Taverna ◽

Seongseok Yun ◽

Jayasree Jonnadula ◽

Ahlam Saleh ◽

Irbaz Bin Riaz ◽

...

Keyword(s):

Systematic Review ◽

Maintenance Therapy ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Hematopoietic Cell ◽

High Dose ◽

Aggressive Lymphomas ◽

Outcomes of high, t(11;14), and standard cytogenetic risk multiple myeloma following early high dose therapy and autologous hematopoietic cell transplantation (SCT).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8583 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8583-8583

Author(s):

Gregory Peter Kaufman ◽

Morie A. Gertz ◽

Angela Dispenzieri ◽

Martha Lacy ◽

Francis Buadi ◽

...

Keyword(s):

Multiple Myeloma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

High Dose ◽

High Dose Therapy ◽

Dose Therapy ◽

Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.8026 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 8026-8026 ◽

Cited By ~ 2

Author(s):

Amarendra Kumar Neppalli ◽

Judith Shizuru ◽

Laura J. Johnston ◽

Lori S. Muffly ◽

Wen-Kai Weng ◽

...

Keyword(s):

Multiple Myeloma ◽

Cell Transplantation ◽

Hematopoietic Cell ◽

High Dose ◽

Long Term Outcomes ◽

High Dose Melphalan ◽

Role of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review

10.1016/j.bbmt.2009.01.022 ◽

2009 ◽

Vol 15 (8) ◽

pp. 893-902 ◽

Cited By ~ 30

Author(s):

Rahul Mhaskar ◽

Ambuj Kumar ◽

Madhusmita Behera ◽

Mohamed A. Kharfan-Dabaja ◽

Benjamin Djulbegovic

Keyword(s):

Systematic Review ◽

Cell Transplantation ◽

High Dose Chemotherapy ◽

Hematopoietic Cell ◽

Systemic Amyloidosis ◽

High Dose ◽